Fig. 3From: Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort studyChest CT scan images (lung window) before and after initiation of target therapy. Images show lungs before and after the initiation of a BRAF-kinase inhibitor (Vemurafenib) and a MEK inhibitor (Cobimetinib)Back to article page